In QuotedData’s morning briefing 6 May 2025:
- Digital 9 Infrastructure (DGI9) has announced that it will be holding a rescheduled presentation for its annual results on Wednesday 7 May 2025. A presentation for analysts, which covers the year ended 31 December 2024, will take place at 10am at the offices of InfraRed Capital Partners. A Q&A session will follow the analyst briefing. Institutional investors are invited to attend via a live webcast, which will also be made available on the company’s website. In a separate development, the company has disclosed that Andrew Zychowski, a non-executive director of DGI9, purchased 450,000 ordinary shares in the company on 2 May 2025 at a price of £0.075866 per share. The total consideration for the purchase was approximately £34,140. This brings Mr Zychowski’s total shareholding, including those held by persons closely associated with him, to 3,080,000 shares. Additionally, other family members hold a further 603,000 shares.
- EJF Investments (EJFI) has announced the results of its rollover offer for holders of its 2025 ZDP shares. Shareholders elected to convert 7.98m 2025 ZDP shares – approximately 41% of those in issue – into new 2029 ZDP shares. These will be rolled over at a value of 139.0980p per share, resulting in the issue of 11.1m new 2029 ZDP shares at a price of 100p per share. The initial placing for the 2029 ZDP shares remains open until 1pm on 9 May 2025, with the company able to issue up to a further 16.9m shares, subject to cover requirements outlined in the prospectus. Admission of the new 2029 ZDP shares – both from the rollover and the placing – is expected to take place on 14 May 2025 on the Specialist Fund Segment of the London Stock Exchange. CREST accounts are expected to be credited the same day, with certificates issued shortly thereafter.
- Polar Capital Global Healthcare (PCGH) has announced the appointment of Caroline Gulliver as an independent non-executive director, effective from 15 May 2025. Ms Gulliver brings significant experience in the investment trust sector, having held non-executive roles at MIGO Opportunities Trust and abrdn European Logistics Income, and previously served as audit chair at International Biotechnology Trust. A former executive director at Ernst & Young, she will join as audit chair-elect and work alongside current audit chair Neal Ransome ahead of his expected retirement in 2026. Her formal election will be proposed at the company’s next AGM in early 2026. Ms Gulliver does not currently hold shares in the trust.
We also have:
Stories you may have missed from Friday: